Skip to content

Genetics of Schizophrenia

Genetics of Schizophrenia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00619437
Enrollment
100
Registered
2008-02-21
Start date
2008-04-30
Completion date
2009-12-31
Last updated
2008-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

schizophrenia, genetics, family, multiplex, haplotypes

Brief summary

Genetic etiology in schizophrenia is widely accepted. However, many chromosomal sites were shown to characterize the families of patients with schizophrenia. This is probably due to the high genetic heterogenity of this illness. Thus, it is important to investigate the genetic factor in relatively genetically homogenous populations. Many studies have indicate that Ashkenazy Jews show relative gentic homogenity. Indeed, the genes responsible for most Mendelian disorders of Jewish peoples have been identified. The study will apply genome-wide mutation screening methods to identify candidate allells in subjects of Ashkenazi Jewish ancestry with multiplex schizophrenia.

Interventions

None listed

Sponsors

Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
FAMILY_BASED
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 78 Years
Healthy volunteers
No

Inclusion criteria

1. Age 18+; 2. Meet DSM-IV criteria for Schizophrenia; 3. At least one first-degree relative who Meet DSM-IV criteria for Schizophrenia; 4. Can sign the informed consent form.

Exclusion criteria

1. Patients suffering from terminal or incurabale disease; 2. Minors, incompetents

Countries

Israel

Contacts

Primary ContactRaz Gross, MD, MPH
razg@gertner.health.gov.il972 3 530 3962

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026